Top upgrades and downgrades on 9/7
Top upgrades and downgrades on 9/7
According to Barclays, the prior rating for Upgrades
升級
BMO Capital upgraded the previous rating for $BRP Inc(DOOO.US)$ from Market Perform to Outperform. For the second quarter, BRP had an EPS of $2.35, compared to year-ago quarter EPS of $0.83. At the moment, the stock has a 52-week-high of $101.08 and a 52-week-low of $46.90. BRP closed at $100.33 at the end of the last trading period.
Guggenheim upgraded the previous rating for $Southern Co(SO.US)$ from Neutral to Buy. In the second quarter, Southern showed an EPS of $0.84, compared to $0.78 from the year-ago quarter. At the moment, the stock has a 52-week-high of $67.46 and a 52-week-low of $51.22. Southern closed at $66.27 at the end of the last trading period.
For $Methanex Corp(MEOH.US)$, Barclays upgraded the previous rating of Equal-Weight to Overweight. Methanex earned $1.24 in the second quarter, compared to $0.84 in the year-ago quarter. The current stock performance of Methanex shows a 52-week-high of $49.27 and a 52-week-low of $21.67. Moreover, at the end of the last trading period, the closing price was at $37.91.
According to Barclays, the prior rating for $Cirrus Logic Inc(CRUS.US)$ was changed from Equal-Weight to Overweight. Cirrus Logic earned $0.54 in the first quarter, compared to $0.53 in the year-ago quarter. The current stock performance of Cirrus Logic shows a 52-week-high of $103.25 and a 52-week-low of $55.84. Moreover, at the end of the last trading period, the closing price was at $83.62.
Needham upgraded the previous rating for $Five9 Inc(FIVN.US)$ from Hold to Buy. For the second quarter, Five9 had an EPS of $0.23, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $211.68 and a 52-week-low of $107.98. At the end of the last trading period, Five9 closed at $170.19.
Deutsche Bank upgraded the previous rating for $Ventas Inc(VTR.US)$ from Hold to Buy. In the second quarter, Ventas showed an EPS of $0.73, compared to $0.77 from the year-ago quarter. The current stock performance of Ventas shows a 52-week-high of $61.09 and a 52-week-low of $37.83. Moreover, at the end of the last trading period, the closing price was at $56.31.
For $Spotify Technology(SPOT.US)$, Keybanc upgraded the previous rating of Sector Weight to Overweight. In the second quarter, Spotify Technology showed an EPS of $0.23, compared to $2.10 from the year-ago quarter. The current stock performance of Spotify Technology shows a 52-week-high of $387.44 and a 52-week-low of $201.68. Moreover, at the end of the last trading period, the closing price was at $249.04.
蒙特利爾銀行資本上調了之前的評級，$BRP Inc.(DOOO.US)$從市場表現到強於大盤。第二季度，BRP的每股收益為2.35美元，而去年同期為0.83美元。目前，該股的52周高點為101.08美元，52周低點為46.9美元。BRP上一交易期尾盤報100.33美元。
古根海姆上調了之前的評級$美國南方公司(SO.US)$從中性到買入。南方航空第二季度每股收益為0.84美元，而去年同期為0.78美元。目前，該股的52周高點為67.46美元，52周低點為51.22美元。Southern上交易期尾盤報66.27美元。
對於$Methanex Corp(MEOH.US)$(投行觀點)，巴克萊將此前評級上調為持平至加碼Methanex第二季度盈利1.24美元，而去年同期為0.84美元。Methanex目前的股票表現顯示，52周高點為49.27美元，52周低點為21.67美元。而且，在上個交易期結束時，收盤價為37.91美元。
根據巴克萊銀行(Barclays)的先前評級，$Cirrus Logic Inc.(CRUS.US)$從等重變為超重。Cirrus Logic第一季度的利潤為0.54美元，而去年同期為0.53美元。Cirrus Logic目前的股票表現顯示，52周高點為103.25美元，52周低點為55.84美元。而且，在上個交易期結束時，收盤價為83.62美元。
李約瑟上調了之前的評級，$Five9 Inc.(FIVN.US)$從持有到買入。第二季度，Five9的每股收益為0.23美元，而去年同期為0.21美元。該股目前的52周高點為211.68美元，52周低點為107.98美元。上交易期尾盤，Five9收報170.19美元。
德意志銀行上調之前的評級為$Ventas Inc.(VTR.US)$從持有到買入。第二季度，Ventas顯示每股收益為0.73美元，而去年同期為0.77美元。Ventas目前的股票表現顯示，52周高點為61.09美元，52周低點為37.83美元。而且，在上個交易期結束時，收盤價為56.31美元。
為$Spotify Technology(Spot.us)$根據Keybanc，Keybanc將之前的板塊權重評級上調至加碼。第二季度，Spotify Technology的每股收益為0.23美元，而去年同期為2.10美元。目前Spotify科技的股票表現顯示，52周高點為387.44美元，52周低點為201.68美元。而且，在上個交易期結束時，收盤價為249.04美元。
Downgrades
降級
Wedbush downgraded the previous rating for $XOMA Corp(XOMA.US)$ from Outperform to Neutral. In the second quarter, XOMA showed an EPS of $0.29, compared to $0.33 from the year-ago quarter. The current stock performance of XOMA shows a 52-week-high of $46.32 and a 52-week-low of $17.66. Moreover, at the end of the last trading period, the closing price was at $28.88.
For $Alliant Energy Corp(LNT.US)$, Guggenheim downgraded the previous rating of Buy to Neutral. For the second quarter, Alliant Energy had an EPS of $0.57, compared to year-ago quarter EPS of $0.54. The stock has a 52-week-high of $62.35 and a 52-week-low of $45.99. At the end of the last trading period, Alliant Energy closed at $61.47.
For $Lam Research(LRCX.US)$, Exane BNP Paribas downgraded the previous rating of Outperform to Neutral. In the fourth quarter, Lam Research showed an EPS of $8.09, compared to $4.78 from the year-ago quarter. The stock has a 52-week-high of $673.80 and a 52-week-low of $292.28. At the end of the last trading period, Lam Research closed at $610.71.
For $Banner Corp(BANR.US)$, DA Davidson downgraded the previous rating of Buy to Neutral. For the second quarter, Banner had an EPS of $1.56, compared to year-ago quarter EPS of $0.67. The stock has a 52-week-high of $60.42 and a 52-week-low of $30.05. At the end of the last trading period, Banner closed at $56.52.
According to Morgan Stanley, the prior rating for $Vertex Pharmaceuticals Inc(VRTX.US)$ was changed from Equal-Weight to Underweight. For the second quarter, Vertex Pharmaceuticals had an EPS of $3.11, compared to year-ago quarter EPS of $2.61. The stock has a 52-week-high of $281.86 and a 52-week-low of $185.32. At the end of the last trading period, Vertex Pharmaceuticals closed at $198.05.
Morgan Stanley downgraded the previous rating for $argenx SE(ARGX.US)$ from Overweight to Equal-Weight. In the second quarter, argenx showed an EPS of $1.98, compared to $3.15 from the year-ago quarter. The current stock performance of argenx shows a 52-week-high of $382.15 and a 52-week-low of $212.66. Moreover, at the end of the last trading period, the closing price was at $350.58.
For $Johnson & Johnson(JNJ.US)$, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Johnson & Johnson earned $2.48 in the second quarter, compared to $1.67 in the year-ago quarter. The current stock performance of Johnson & Johnson shows a 52-week-high of $179.92 and a 52-week-low of $133.65. Moreover, at the end of the last trading period, the closing price was at $175.04.
Morgan Stanley downgraded the previous rating for $Merck & Co Inc(MRK.US)$ from Overweight to Equal-Weight. In the second quarter, Merck & Co showed an EPS of $1.31, compared to $1.37 from the year-ago quarter. The current stock performance of Merck & Co shows a 52-week-high of $87.80 and a 52-week-low of $15.32. Moreover, at the end of the last trading period, the closing price was at $77.26.
Wolfe Research downgraded the previous rating for $Carrier Global(CARR.US)$ from Outperform to Peer Perform. Carrier Global earned $0.64 in the second quarter, compared to $0.33 in the year-ago quarter. The current stock performance of Carrier Global shows a 52-week-high of $58.89 and a 52-week-low of $28.58. Moreover, at the end of the last trading period, the closing price was at $57.41.
Morgan Stanley downgraded the previous rating for $Amgen(AMGN.US)$ from Overweight to Equal-Weight. In the second quarter, Amgen showed an EPS of $4.38, compared to $4.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of $276.69 and a 52-week-low of $210.28. Amgen closed at $226.37 at the end of the last trading period.
For $JOANN Inc.(JOAN.US)$, Barclays downgraded the previous rating of Overweight to Equal-Weight. Interestingly, in the second quarter, JOANN's EPS was $0.20. The stock has a 52-week-high of $17.50 and a 52-week-low of $9.75. At the end of the last trading period, JOANN closed at $10.28.
韋德布什將之前的評級下調為$XOMA公司(XOMA.US)$從強於大盤到中性。第二季度，XOMA顯示每股收益為0.29美元，而去年同期為0.33美元。XOMA目前的股票表現顯示，52周高點為46.32美元，52周低點為17.66美元。而且，在上個交易期結束時，收盤價為28.88美元。
為$Alliant Energy Corp(LNT.US)$根據Guggenheim的評級，Guggenheim將之前的買入評級下調至中性。第二季度，Alliant Energy的每股收益為0.57美元，而去年同期為0.54美元。該股目前的52周高點為62.35美元，52周低點為45.99美元。上一交易期尾盤，Alliant Energy收報61.47美元。
為$LAM Research(LRCX.US)$根據法國巴黎銀行(Exane BNP Paribas)，Exane BNP Paribas將之前的評級下調為表現優於大盤至中性。LAM Research顯示，第四季度每股收益為8.09美元，而去年同期為4.78美元。該股目前的52周高點為673.80美元，52周低點為292.28美元。上一交易期尾盤，LAM Research收報610.71美元。
為$Banner Corp(BANR.US)$此前，DA Davidson將買入評級下調至中性。第二季度，Banner的每股收益為1.56美元，而去年同期為0.67美元。該股目前的52周高點為60.42美元，52周低點為30.05美元。上交易期尾盤，Banner收報56.52美元。
據摩根士丹利介紹，該公司此前的評級為$Vertex製藥公司(VRTX.US)$從等重改為過輕。第二季度，Vertex製藥公司的每股收益為3.11美元，而去年同期為2.61美元。該股目前的52周高點為281.86美元，52周低點為185.32美元。上一交易期尾盤，頂點製藥收報198.05美元。
摩根士丹利將之前的評級下調為$argenx SE(ARGX.US)$從超重到等重。第二季度，argenx顯示每股收益為1.98美元，而去年同期為3.15美元。Argenx目前的股票表現顯示，52周高點為382.15美元，52周低點為212.66美元。而且，在上個交易期結束時，收盤價為350.58美元。
為$強生(JNJ.US)$此前，摩根士丹利將評級下調至增持至持平。強生第二季度的收入為2.48美元，而去年同期為1.67美元。強生目前的股票表現顯示，52周高點為179.92美元，52周低點為133.65美元。而且，在上個交易期結束時，收盤價為175.04美元。
摩根士丹利將之前的評級下調為$默沙東(MRK.US)$從超重到等重。默克公司(Merck&Co)第二季度每股收益為1.31美元，而去年同期為1.37美元。默克公司目前的股票表現顯示52周高點87.80美元和52周低點15.32美元。而且，在上個交易期結束時，收盤價為77.26美元。
Wolfe Research下調了之前的評級，$Carrier Global(CARR.US)$從強於大盤到同業大盤。環球航空第二季度盈利0.64美元，而去年同期為0.33美元。Carrier Global目前的股票表現顯示，52周高點為58.89美元，52周低點為28.58美元。而且，在上個交易期結束時，收盤價為57.41美元。
摩根士丹利將之前的評級下調為$Amgen(AMGN.US)$從超重到等重。第二季度，安進顯示每股收益為4.38美元，而去年同期為4.25美元。目前，該股的52周高點為276.69美元，52周低點為210.28美元。安進上一交易期尾盤報226.37美元。
為$Joann Inc.(JOAN.US)$(投行觀點)，巴克萊將之前的評級下調至增持至持平有趣的是，在第二季度，喬安的每股收益為0.20美元。該股目前的52周高點為17.50美元，52周低點為9.75美元。上個交易期結束時，Joann收報10.28美元。
Initiations
啟蒙行動
Zelman initiated coverage on $Opendoor(OPEN.US)$ with a Buy rating. In the second quarter, Opendoor Technologies showed an EPS of $0.24, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $39.24 and a 52-week-low of $13.44. Opendoor Technologies closed at $19.18 at the end of the last trading period.
With a Buy rating, Alliance Global Partners initiated coverage on $Greenlane Holdings Inc(GNLN.US)$. The price target seems to have been set at $6.00 for Greenlane Hldgs. In the second quarter, Greenlane Hldgs showed an EPS of $0.22, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $8.73 and a 52-week-low of $1.83. At the end of the last trading period, Greenlane Hldgs closed at $2.73.
With an Outperform rating, Wedbush initiated coverage on $Tango Therapeutics Inc(TNGX.US)$. The price target seems to have been set at $20.00 for Tango Therapeutics. Tango Therapeutics closed at $12.93 at the end of the last trading period.
With an Overweight rating, Morgan Stanley initiated coverage on $Valero Energy Corp(VLO.US)$. The price target seems to have been set at $80.00 for Valero Energy. In the second quarter, Valero Energy showed an EPS of $0.48, compared to $1.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of $84.95 and a 52-week-low of $35.44. Valero Energy closed at $64.70 at the end of the last trading period.
Morgan Stanley initiated coverage on $Phillips 66(PSX.US)$ with a Equal-Weight rating. The price target for Phillips 66 is set to $80.00. In the second quarter, Phillips 66 showed an EPS of $0.74, compared to $0.74 from the year-ago quarter. At the moment, the stock has a 52-week-high of $94.34 and a 52-week-low of $43.27. Phillips 66 closed at $69.62 at the end of the last trading period.
With a Equal-Weight rating, Morgan Stanley initiated coverage on $PBF Energy Inc(PBF.US)$. The price target seems to have been set at $12.00 for PBF Energy. For the second quarter, PBF Energy had an EPS of $1.26, compared to year-ago quarter EPS of $3.19. The stock has a 52-week-high of $18.78 and a 52-week-low of $4.06. At the end of the last trading period, PBF Energy closed at $9.63.
With a Buy rating, Jefferies initiated coverage on $Celcuity Inc(CELC.US)$. The price target seems to have been set at $48.00 for Celcuity. In the second quarter, Celcuity showed an EPS of $0.66, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $33.01 and a 52-week-low of $5.00. Celcuity closed at $21.50 at the end of the last trading period.
Evercore ISI Group initiated coverage on $Avidity Biosciences(RNA.US)$ with an Outperform rating. The price target for Avidity Biosciences is set to $50.00. For the second quarter, Avidity Biosciences had an EPS of $0.70, compared to year-ago quarter EPS of $1.23. The current stock performance of Avidity Biosciences shows a 52-week-high of $37.46 and a 52-week-low of $17.58. Moreover, at the end of the last trading period, the closing price was at $19.24.
澤爾曼發起了關於$OpenDoor(OPEN.US)$評級為買入。在第二季度，OpenDoor Technologies顯示每股收益為0.24美元，而去年同期為0.66美元。目前，該股的52周高點為39.24美元，52周低點為13.44美元。OpenDoor Technologies上一交易期尾盤報19.18美元。
憑藉買入評級，Alliance Global Partners在$Greenane Holdings Inc(GNLN.US)$。綠巷Hldgs的目標價似乎被設定在6.00美元。第二季度，Greenane Hldgs顯示每股收益為0.22美元，而去年同期為0.46美元。該股目前的52周高點為8.73美元，52周低點為1.83美元。綠巷Hldgs上一交易期尾盤報2.73美元。
憑藉強於大盤的評級，韋德布什在$Tango治療公司(TNGX.US)$。探戈治療公司的目標價格似乎被設定在20.00美元。探戈治療公司上一交易期尾盤收報12.93美元。
加碼收視率，摩根士丹利啟動報道$Valero Energy Corp(VLO.US)$。瓦萊羅能源的目標價似乎被設定在80.00美元。第二季度，Valero Energy顯示每股收益為0.48美元，而去年同期為1.25美元。目前，該股的52周高點為84.95美元，52周低點為35.44美元。瓦萊羅能源上交易期尾盤收報64.70美元。
摩根士丹利發起了對……的報道。$Phillips 66(PSX.US)$擁有同等重量的評級。菲利普斯66的目標價定為80.00美元。第二季度，菲利普斯66的每股收益為0.74美元，而去年同期為0.74美元。目前，該股的52周高點為94.34美元，52周低點為43.27美元。Phillips 66上交易期尾盤收報69.62美元。
在同等權重的評級下，摩根士丹利啟動了對$PBF Energy Inc.(PBF.US)$。PBF Energy的目標價似乎被設定在12.00美元。第二季度，PBF Energy的每股收益為1.26美元，而去年同期為3.19美元。該股目前的52周高點為18.78美元，52周低點為4.06美元。上一交易期尾盤，PBF Energy收報9.63美元。
在獲得買入評級的情況下，Jefferies在$Celcuity Inc.(CELC.US)$。Celcuity的目標價似乎被設定在48.00美元。第二季度，Celcuity的每股收益為0.66美元，而去年同期為0.17美元。目前，該股的52周高點為33.01美元，52周低點為5.00美元。Celcuity上一交易期尾盤報21.50美元。
Evercore ISI Group在$Avidity Biosciences(RNA.US)$評級優於大盤。Avidity Biosciences的目標價定為50.00美元。第二季度，Avidity Biosciences的每股收益為0.70美元，而去年同期為1.23美元。Avidity Biosciences目前的股票表現顯示，52周高點為37.46美元，52周低點為17.58美元。而且，在上個交易期結束時，收盤價為19.24美元。